Editorial: Personalized medicine and infectious disease management

Abstract

The importance of personalized medicine in the healthcare management of several diseases is well-documented. Still, very little is known about the role of genetics in susceptibility or resistance to infectious diseases (1). Following the emergence of SARS-CoV-2, it became prominent that the genetic background of the patient influences the disease prognosis and treatment. Therefore, multiple genetic databases were established to study precision medicine for COVID-19 (2). This Research Topic gathered different contributions demonstrating the impact of genetic determinants in infectious diseases prognosis and clinical outcome. Ten articles were published in this editorial topic, including five research articles, three reviews, and two case studies.